Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Saulay · SciRah

Researcher profile · Semantic Scholar

M. Saulay

Share profile

M. Saulay — researcher profile on SciRah

h-index: 10
Works: 21
Citations: 560

Most-cited papers

A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
S. Awad, Alejandro Rodríguez, Yin-Ching Chuang, Z. Marjanek +7 more
2014Clinical Infectious Diseases216 citations Open access
Semantic Scholar
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
Thomas L. Holland, Sara E. Cosgrove, S. Doernberg, Timothy C. Jenkins +19 more
2023New England Journal of Medicine75 citations Open access
Semantic Scholar
Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases
T. Kaindl, D. Andes, M. Engelhardt, M. Saulay +2 more
2018Journal of Antimicrobial Chemotherapy69 citations Open access
Semantic Scholar
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)
J. Overcash, Charles C. Kim, Richard C. Keech, Illia Gumenchuk +10 more
2020Clinical Infectious Diseases65 citations Open access
Semantic Scholar
Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial
K. Hamed, M. Engelhardt, Mark E. Jones, M. Saulay +3 more
2020Future Microbiology31 citations Open access
Semantic Scholar
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials
T. Scheeren, T. Welte, M. Saulay, M. Engelhardt +2 more
2019BMC Infectious Diseases25 citations Open access
Semantic Scholar
Efficacy of derazantinib (DZB) in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) expressing FGFR2-fusion or FGFR2 mutations/amplifications
M. D. Busset, S. Braun, B. El-Rayes, W. Harris +14 more
2019Annals of Oncology18 citations Open access
Semantic Scholar
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients
M. Bosheva, Rusudan Gujabidze, É. Károly, Á. Németh +3 more
2021The Pediatric Infectious Disease Journal12 citations Open access
Semantic Scholar
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole
J. Maertens, D. Selleslag, W. Heinz, M. Saulay +9 more
2018Mycoses (Berlin)12 citations Open access
Semantic Scholar
Derazantinib (DZB) in combination with atezolizumab (AZB) in patients with solid tumors: Results from the dose-finding phase Ib substudy of FIDES-02.
R. Abdul-Karim, A. Chaudhry, A. Patrikidou, Alejandro Falcón González +10 more
202110 citations
Semantic Scholar
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations
A. Necchi, R. Ramlau, Alejandro Falcón González, A. Chaudhry +18 more
2024JNCI Cancer Spectrum9 citations Open access
Semantic Scholar
Efficacy and safety of ceftobiprole in patients aged 65 years or older: a post hoc analysis of three Phase III studies.
T. Welte, T. Scheeren, J. Overcash, M. Saulay +2 more
2021Future Microbiology8 citations Open access
Semantic Scholar
Derazantinib (DZB) provides antitumor efficacy regardless of line of therapy in patients (pts) with FGFR2-fusion positive advanced intrahepatic cholangiocarcinoma (iCCA).
Michele Droz Dit Busset, B. El-Rayes, W. Harris, N. Damjanov +15 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance
A. F. Shorr, Mark E. Jones, Silke Friedmann, D. Ionescu +3 more
2025PLoS ONE3 citations Open access
Semantic Scholar
Efficacy and safety of derazantinib (DZB) in patients with metastatic urothelial carcinoma (mUC) with activating FGFR1/2/3 genetic aberrations (GA): Results from the phase 1b/2 FIDES-02 study
A. Necchi, T. Todenhöfer, J. Deville, M. Häckl +5 more
2023European Urology3 citations
Semantic Scholar
A post hoc analysis of two Phase III trials showing efficacy and tolerability of ceftobiprole in East Asian patients.
Hai-Hui Huang, Lei Gao, M. Engelhardt, M. Saulay +1 more
2021Future Microbiology3 citations Open access
Semantic Scholar
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials
T. L. Holland, A. F. Shorr, J. Overcash, Marc Engelhardt +5 more
2025Journal of Antimicrobial Chemotherapy1 citations Open access
Semantic Scholar
2561. Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies
A. Cammarata, K. Litherland, M. Safir, S. Bhavnani +5 more
2023Open Forum Infectious Diseases0 citations Open access
Semantic Scholar
1149. Baseline Chest CT Findings in Patients with Pulmonary Mold Infections: A Post-Hoc Analysis from the Phase 3 SECURE Study that Compared Isavuconazole to Voriconazole for the Primary Treatment of Invasive Mold Disease
K. Hamed, M. Engelhardt, M. Saulay, L. Kovanda
2020Open Forum Infectious Diseases0 citations Open access
Semantic Scholar
1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope® Registry
D. Seidel, O. Cornely, M. Vehreschild, P. Koehler +18 more
2020Open Forum Infectious Diseases0 citations Open access
Semantic Scholar
Efficacy and tolerability of ceftobiprole medocaril in China, South Korea, and Taiwan: Post-hoc analysis of two randomized trials in community-acquired and hospital-acquired pneumonia
Yin-Ching Chuang, M. Saulay, D. Main, M. Engelhardt +1 more
20150 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Engelhardt×13
Invite
M. Engelhardt — researcher profile on SciRah
K. Hamed×8
Invite
K. Hamed — researcher profile on SciRah
Marc Engelhardt×6
Invite
Marc Engelhardt — researcher profile on SciRah
Mark E. Jones×5
Invite
Mark E. Jones — researcher profile on SciRah

Jennifer I. Smart

×4

Invite

Jennifer I. Smart — researcher profile on SciRah

Invite

T. Scheeren — researcher profile on SciRah

Invite

D. Ionescu — researcher profile on SciRah

Invite

J. Overcash — researcher profile on SciRah

Invite

J. Deville — researcher profile on SciRah

Michalina Marszewska×3

Invite

Michalina Marszewska — researcher profile on SciRah

Yin-Ching Chuang×2

Invite

Yin-Ching Chuang — researcher profile on SciRah

Invite

V. Fowler — researcher profile on SciRah